Yasushi Shigeoka Selected Research

Yasushi Shigeoka Research Topics

Disease

7	Neoplasms (Cancer) 06/2021 - 03/2004
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2009 - 01/2003
4	Breast Neoplasms (Breast Cancer) 06/2021 - 03/2008
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2010 - 04/2008
3	Lung Neoplasms (Lung Cancer) 10/2007 - 06/2004
3	Adenocarcinoma of Lung 03/2005 - 03/2004
2	Neutropenia 03/2009 - 10/2007
2	Carcinoma (Carcinomatosis) 11/2005 - 10/2003
1	Colorectal Neoplasms (Colorectal Cancer) 10/2019
1	Nausea 08/2019
1	Vomiting 08/2019
1	Bone Resorption 01/2015
1	Asthma (Bronchial Asthma) 07/2009
1	Respiratory Hypersensitivity 07/2009
1	Fever (Fevers) 03/2009
1	Disease Progression 04/2008
1	Leukopenia 10/2007
1	Diarrhea 10/2007
1	Hypersensitivity (Allergy) 01/2007
1	Embryonal Carcinoma 11/2005
1	Neoplasm Metastasis (Metastasis) 11/2005
1	Pneumonia (Pneumonitis) 01/2004
1	Chronic Obstructive Pulmonary Disease (COPD) 12/2003
1	Carcinogenesis 10/2003

Drug/Important Bio-Agent (IBA)

6	Paclitaxel (Taxol)FDA LinkGeneric 03/2008 - 01/2003
3	Cisplatin (Platino)FDA LinkGeneric 04/2008 - 10/2003
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2010 - 03/2005
2	amrubicinIBA 01/2010 - 03/2009
2	Vinorelbine (Navelbine)FDA LinkGeneric 03/2009 - 11/2004
2	Irinotecan (Camptosar)FDA LinkGeneric 04/2008 - 10/2007
2	Fluorouracil (Carac)FDA LinkGeneric 04/2008 - 11/2004
2	Dexamethasone (Maxidex)FDA LinkGeneric 03/2008 - 01/2007
2	Retinoblastoma ProteinIBA 01/2007 - 06/2004
1	Trifluridine (Viroptic)FDA LinkGeneric 10/2019
1	DNA (Deoxyribonucleic Acid)IBA 10/2019
1	trifluridine tipiracil drug combinationIBA 10/2019
1	AnthracyclinesIBA 08/2019
1	NitrogenIBA 01/2015
1	Diphosphonates (Bisphosphonates)IBA 01/2015
1	Zoledronic Acid (Zometa)FDA Link 01/2015
1	Mevalonic Acid (Mevalonate)IBA 01/2015
1	Imatinib Mesylate (Gleevec)FDA Link 01/2010
1	Leukotriene B4 Receptors (Leukotriene B4 Receptor)IBA 07/2009
1	OvalbuminIBA 07/2009
1	Leukotriene B4IBA 07/2009
1	Tyrosine Kinase InhibitorsIBA 03/2009
1	UracilIBA 03/2009
1	TegafurIBA 03/2009
1	Trastuzumab (Herceptin)FDA Link 03/2008
1	GlucocorticoidsIBA 01/2007
1	Granisetron (Kytril)FDA LinkGeneric 01/2006
1	Docetaxel (Taxotere)FDA Link 01/2006
1	Monoclonal AntibodiesIBA 11/2005
1	acarboxyprothrombin (PIVKA)IBA 11/2005
1	Histone Deacetylase InhibitorsIBA 03/2005
1	romidepsin (FK228)FDA Link 03/2005
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 06/2004
1	Transforming Growth Factor beta (TGF-beta)IBA 03/2004
1	CurcuminIBA 03/2004
1	Catechin (Z 7300)IBA 03/2004
1	caffeic acid phenethyl esterIBA 03/2004
1	sulindac sulfideIBA 03/2004
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2004
1	AntioxidantsIBA 12/2003
1	Biomarkers (Surrogate Marker)IBA 12/2003
1	VitaminsIBA 12/2003
1	8-Hydroxy-2'-DeoxyguanosineIBA 12/2003
1	Phosphotransferases (Kinase)IBA 10/2003
1	Y 27632IBA 10/2003
1	Focal Adhesion Protein-Tyrosine KinasesIBA 10/2003

Therapy/Procedure

7	Drug Therapy (Chemotherapy) 06/2021 - 11/2004
3	Therapeutics 01/2004 - 01/2003
1	Oral Administration 06/2021
1	Neoadjuvant Therapy 01/2015